A third dose of #AstraZeneca's (@AstraZeneca) #CovidVaccine, named #Covishield in India, increases antibody response to the new vaccine-evading #OmicronVariant, according to a new trial published by the British-Swedish drugmaker on Thursday. pic.twitter.com/xO5tJtqkQr— IANS Tweets (@ians_india) January 13, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


